Steris Pharma in Jaipur, INDIA

Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

Steris Healthcare Pvt Ltd, We are delighted to introduce ourselves as STERIS HEALTHCARE PVT LTD is a specialty pharmaceutical company formed in the February month of year 2015 by a group of extensively proficient pharmaceutical pr ...

Read More Contact Us

Steris Healthcare Pvt Ltd, We are delighted to introduce ourselves as STERIS HEALTHCARE PVT LTD is a specialty pharmaceutical company formed in the February month of year 2015 by a group of e... read more

Our Medicines

LINALIGLIP M 5/500

INR 172 INR 245
You Save: INR 29.8%

LINALIGLIP 2.5/500 Linagliptin & Metformin HydrochlorideIntroduction:The management of type 2 diabetes mellitus (T2DM) often necessitates a multifaceted approach, combining lifestyle modifications, dietary interventions, and pharmacotherapy. Among the pharmacological agents commonly prescribed for T2DM, both Linagliptin and Metformin Hydrochloride stand out for their efficacy and safety profiles. The combination of these two medications in LINALIGLIP 2.5/500 offers a synergistic approach to glycemic control. This article explores the rationale behind combining Linagliptin and Metformin Hydrochloride, their individual mechanisms of action, and the clinical implications of LINALIGLIP 2.5/500 in the management of T2DM.Understanding the Components:LINALIGLIP 2.5/500 comprises two active ingredients: Linagliptin and Metformin Hydrochloride. Linagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, which enhance the activity of incretin hormones, such as glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and suppressing glucagon release. Metformin Hydrochloride, on the other hand, is a biguanide that primarily works by reducing hepatic glucose production, improving insulin sensitivity, and decreasing intestinal glucose absorption.Synergistic Mechanisms of Action:The combination of Linagliptin and Metformin Hydrochloride in LINALIGLIP 2.5/500 capitalizes on their complementary mechanisms of action. Linagliptin enhances insulin secretion and suppresses glucagon release, primarily targeting postprandial glucose excursions. Meanwhile, Metformin Hydrochloride reduces hepatic glucose output, improves insulin sensitivity, and enhances peripheral glucose uptake, primarily addressing fasting hyperglycemia. Together, these medications offer comprehensive glycemic control, targeting both fasting and postprandial glucose levels.Efficacy in Glycemic Control:Clinical studies have demonstrated the efficacy of LINALIGLIP 2.5/500 in improving glycemic control in patients with T2DM. The combination therapy has been shown to reduce hemoglobin A1c (HbA1c) levels to a greater extent than either Linagliptin or Metformin Hydrochloride alone. Additionally, the dual-action approach of LINALIGLIP 2.5/500 offers advantages in terms of durability and sustainability of glycemic control over the long term, thereby reducing the risk of diabetes-related complications. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 BUY NOWhttps://www.sterisonline.com/product/linaliglip-2-5-500-134273

LINALIGLIP 2.5/500

INR 179 INR 255
You Save: INR 29.8%

LINALIGLIP DAPA 5-10 Linagliptin 5 mg & Dapagliflozin 10 mgIntroduction:Diabetes mellitus poses a significant public health challenge, with its prevalence continuing to rise globally. In the quest for effective management strategies, the combination of multiple therapeutic agents with complementary mechanisms of action has gained traction. LINALIGLIP DAPA 5-10, a novel formulation combining Linagliptin 5 mg and Dapagliflozin 10 mg, represents a groundbreaking approach to diabetes care. This article explores the synergistic benefits, efficacy, and clinical implications of LINALIGLIP DAPA 5-10 in the management of type 2 diabetes mellitus (T2DM).Understanding the Mechanisms of Action:LINALIGLIP DAPA 5-10 combines two distinct classes of antidiabetic medications: Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Linagliptin enhances the activity of incretin hormones, such as glucagon-like peptide-1 (GLP-1), promoting insulin secretion and suppressing glucagon release. Dapagliflozin, on the other hand, inhibits renal glucose reabsorption, leading to increased urinary glucose excretion and subsequent lowering of blood glucose levels. By targeting different pathways involved in glucose regulation, LINALIGLIP DAPA 5-10 offers a comprehensive approach to glycemic control.Synergistic Benefits:The combination of Linagliptin and Dapagliflozin in LINALIGLIP DAPA 5-10 provides several synergistic benefits. Firstly, the dual action of these agents targets multiple aspects of glucose homeostasis, resulting in greater reductions in hemoglobin A1c (HbA1c) levels compared to monotherapy with either component alone. Secondly, Dapagliflozin's mechanism of action leads to diuretic effects, reducing blood pressure and promoting weight loss, which complements the glucose-lowering effects of Linagliptin. Finally, the combination therapy may offer cardiovascular and renal protective benefits, as suggested by clinical trials evaluating SGLT2 inhibitors. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 BUY NOWhttps://www.sterisonline.com/product/linaliglip-dapa-5-10-134320

LINALIGLIP DAPA 5-10

INR 172 INR 245
You Save: INR 29.8%

View All Medicines

about Steris Pharma

about our organization

Steris Healthcare Pvt Ltd, We are delighted to introduce ourselves as STERIS HEALTHCARE PVT LTD is a specialty pharmaceutical company formed in the February month of year 2015 by a group of extensively proficient pharmaceutical pr...Read More

917
Medicines Available

lATEST NEWS

SACUBRIGHT 50 Sacubitril (24mg), Valsartan (26mg)

SACUBRIGHT 50 Sacubitril (24mg), Valsartan (26mg) SACUBRIGHT 50 combination of Sacubitril...

CRAVORINE 20 Caroverine (20mg) CRAVORINE 20 is a m

CRAVORINE 20 Caroverine (20mg) CRAVORINE 20 is a medication containing Caroverine, utiliz...

STERIS'S LACTULOSE 150 ML Lactulose Solution USP S

STERIS'S LACTULOSE 150 ML Lactulose Solution USP STERIS'S LACTULOSE 150 ML , commonly ref...

VIEW ALL UPDATES

Our Gallery

Request a Call Back

Any Questions About Us?

If you have any kind of query, please don't hesitate to contact us on our Email and you can also contact by calling page08048129013